Kurzvorträge Die Vortragssprache richtet sich nach der Fachgesellschaft. Calcium channels Jörg Striessnig (Innsbruck) First author City, Country
Agonist evoked Ca2+ elevation in mast 314
Transporter Birgitta Burckhardt (Göttingen) First author City, Country
severe leukopenia, strongly reduces ABCC11 transport activity in vitro
cotransporter 3 (NaDC3) and of the organic anion transporter 1 (OAT1)
Protein kinases Tatiana Syrovets (Ulm) First author City, Country
pathway, G2 cell cycle arrest, and apoptosis in chemoresistant prostate cancer cells
Cyclic Nucleotides Slava Nikolaev (Göttingen) First author City, Country
characterization and first in vivo
receptor-microdomain communication in cardiac hypertrophy
Bacterial toxins Jan Hengstler (Dortmund) and Wim Wätjen (Halle) First author City, Country
Enzyme-deficient C3-E174Q from C.
cyclophilins and FK506-binding proteins for membrane translocation
Clostridium difficile toxin B induces
Clostridium perfringens TpeL toxin
indicates a two-receptor model of clostridial glycosylating toxins
Oxidative and radiation stress Cornelia Dietrich (Mainz) First author City, Country
against genotoxic stress in the in vivo model organism C. elegans
factor Nrf2 in kidney cells both in vitro Caenorhabditis elegans by baicalein derivatives
Cardiovascular system Justus Stenzig (Hamburg) First author City, Country
Effects of maternal PETN treatment of 468
Toxic substances and metabolism Charlotte Esser (Düsseldorf) and Albert Braeuning (Tübingen) First author City, Country
cytochrome P450 1A1 yielding glutathione and protein adducts
Formation of cytotoxic benzo[a ]pyrene- 183
Green tea and one of its constituents, 289
inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
Toxic substances Helga Stopper (Würzburg) First author City, Country
Correlation between in-vivo and in-vitro combination effects of triazole
fungicides in the adrenal gland and H295R cells
Ludwigshafen, Testing mixtures in vivo at human-
Velocity of the release of free cyanide 484
cyanogenic glycosides after tissue destruction as important factor determining their toxicity
Small and heterotrimeric G proteins Joachim Orth (Freiburg) First author City, Country
Enhanced sensitivity of phospholipase 293
lymphocytic leukaemia resistance to the Bruton´s tyrosine kinase inhibitor ibrutinib in vivoPasteurella multocida toxin stimulates 217
osteoclast differentiation by activation
Central nervous system Marion Bankstahl (Hannover) Immunopharmacology (I) Martina Schmidt (Groningen, NL) First author City, Country aeruginosa , a bacterium critical to cystic fibrosis patients
PLAID, a novel form of human hereditary antibody deficiency and immune dysregulation
Immunopharmacology (II) Detlef Neumann (Hannover)
phosphate enhancesCOX-2 expression and migration in human monocytes
remodeling processes induced by cigarette smoke
GPCRs (I) Martin Göttle, Hannover (Germany) First author City, Country
receptor binding in hematopoietic cells from rat spleen and bone marrow?
Quantifying ligand bias of enantiopure 166
GPCRs (II) Andreas Bock (Würzburg)
Genetic dissection of plexin signalling 165
Differential participation of Gβγ in the
Clinical Pharmacology (I) Jens Tank (Hannover) First author City, Country
and metabolism in obese hypertensive patients
the worldwide genetic variability in the OCT1 gene?
and mir-132. Results from a genomewide miRNA screen in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Clinical Pharmacology (II) Renke Maas (Erlangen) Eleutherococcus senticosus , radix,
with respect to its safety in hypertensive patients
improving medication safety in ambulatory care
Mutagenesis, carcinogenesis and cancer Gerhard Fritz (Mainz) and Nicole Schupp (Würzburg) First author City, Country
cellular senescence in human peritoneal mesothelial LP9 cells
dynamics in human keratinocytes with distinctive effects on genotoxicity
highly expressed genes which are characterized by topoisomerase IIα enrichment at promoters
ErbB3 in the nucleus – mechanisms of 432
Implications for their carcinogenic mode of action
methyltransferase (MGMT) in vitro and in colorectal cancer cells
Aliment Pharmacol Ther 2004; 19: 1105–1110. Effect of splitting the dose of esomeprazole on gastric acidityand nocturnal acid breakthroughJ . H A M M E R & B . S C H M I D TUniversita¨tsklinik fu¨r Innere Medizin IV, Abteilung fu¨r Gastroenterologie und Hepatologie, Vienna, AustriaResults: Median gastric 24-h pH was higher during 2· 20 mg esomeprazole on day 2 (P < 0.01), noBackg
M DREAM INWORLD LIMITED (Incorporated in the Cayman Islands with limited liability) FORM OF PROXY Form of proxy for use by shareholders at the extraordinary general meeting of M Dream Inworld Limited to be held at Phoenix Room, The Charterhouse Hotel, 209-219 Wanchai Road, Hong Kong on Thursday, 29 October 2009 at 10:00 a.m. and at any adjournment thereof. (note b) shares of HK$0.0
Kurzvorträge